c.i. direct red 80 has been researched along with Cardiovascular Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alves-Lopes, R; Berry, C; Caputo, I; Fallon, K; Jamieson, NB; Kamdar, A; Legrini, A; Leslie, H; Mangion, K; McAbney, J; McConnachie, A; McFarlane, RW; McIntosh, A; Montezano, AC; Morrow, A; Neves, KB; Sykes, RA; Touyz, RM; Wood, C | 1 |
1 other study(ies) available for c.i. direct red 80 and Cardiovascular Diseases
Article | Year |
---|---|
Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Cardiovascular Diseases; COVID-19; Female; Humans; Male; Middle Aged; Post-Acute COVID-19 Syndrome; rho-Associated Kinases | 2023 |